^
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
imatinib Sensitive: A1 - Approval
|
imatinib Sensitive: A1 - Approval
|
KIT M541L
|
Chronic Eosinophilic Leukemia
|
KIT M541L
|
Chronic Eosinophilic Leukemia
|
imatinib Sensitive: C3 – Early Trials
|
imatinib Sensitive: C3 – Early Trials
|
PCM1-JAK2 fusion
|
Chronic Eosinophilic Leukemia
|
PCM1-JAK2 fusion
|
Chronic Eosinophilic Leukemia
|
ruxolitinib Sensitive: C3 – Early Trials
|
ruxolitinib Sensitive: C3 – Early Trials
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
FIP1L1-PDGFRA fusion
|
Chronic Eosinophilic Leukemia
|
YD312 Sensitive: C4 – Case Studies
|
YD312 Sensitive: C4 – Case Studies
|
